Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,846 | -240,053 | -157,128 | -230,026 | -246,290 |
| Depreciation Amortization | 3,276 | 3,267 | 2,388 | 2,630 | 2,188 |
| Income taxes - deferred | N/A | 37,104 | -1,621 | -26,049 | N/A |
| Accounts receivable | 4,771 | 47,789 | -42,753 | -30,218 | N/A |
| Accounts payable and accrued liabilities | 2,462 | 3,173 | 310 | 6,798 | 1,921 |
| Other Working Capital | 5,784 | 45,987 | -48,725 | -15,710 | 12,362 |
| Other Operating Activity | 17,718 | -15,953 | 109,218 | 59,197 | 61,090 |
| Operating Cash Flow | $-123,835 | $-118,686 | $-138,311 | $-233,378 | $-168,729 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -867 | -3,216 | -687 | -3,430 | -801 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2,946 | -2,008 |
| Other Investing Activity | 0 | 0 | 0 | -3,243 | -2,027 |
| Investing Cash Flow | $-867 | $-3,216 | $-687 | $-6,673 | $-2,828 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 115,597 | 49,591 | 62,898 |
| Debt Repayment | N/A | N/A | -118,304 | N/A | N/A |
| Common Stock Issued | 98,217 | 773 | 6,130 | 778 | 433,212 |
| Other Financing Activity | -1,163 | 73,102 | -4,320 | 217,025 | -1,144 |
| Financing Cash Flow | $97,054 | $73,875 | $-897 | $267,394 | $494,966 |
| Exchange Rate Effect | -83 | 184 | -208 | 6 | 235 |
| Beginning Cash Position | 278,598 | 326,441 | 466,544 | 439,195 | 115,551 |
| End Cash Position | 250,867 | 278,598 | 326,441 | 466,544 | 439,195 |
| Net Cash Flow | $-27,731 | $-47,843 | $-140,103 | $27,349 | $323,644 |
| Free Cash Flow | |||||
| Operating Cash Flow | -123,835 | -118,686 | -138,311 | -233,378 | -168,729 |
| Capital Expenditure | -867 | -3,216 | -687 | -3,430 | -801 |
| Free Cash Flow | -124,702 | -121,902 | -138,998 | -236,808 | -169,530 |